Quantum Insights
QUANTUM / QUANTUM INSIGHTSResearch for founders, funds and investors.
Ideas, market perspectives and investment intelligence from the worlds of venture capital, healthcare and technology.
Latest insights
Valuation · September 1, 2026
Biotech Startup Valuation: rNPV in Practice
Valuing a biotech startup is unlike valuing almost any other kind of company. There's often no revenue, sometimes no product candidate that has reached the clinic, and the central question investors are trying to answer isn't "how fast is this growing" but "what is the […]
Read insight
Venture Capital · February 15, 2026
Top Healthcare & Biotech US VC Firms in 2026
Healthcare and biotech remain among the most capital-intensive, expertise-driven corners of venture investing. Backing a therapeutics or medtech company requires more than a checkbook — it requires investors who understand clinical trial design, regulatory pathways, reimbursement dynamics, and the long time horizons that define life […]
Read insight
Venture Capital · October 15, 2025
Top US Life Sciences VC Firms in 2026
Life sciences remains one of the most capital-intensive and scientifically demanding venture categories, requiring investors with deep domain expertise in drug development, regulatory pathways, and clinical trial design. Below is a look at nine active US life sciences venture firms founders should know heading into […]
Read insight
Venture Capital · March 15, 2025
Top Healthcare & Biotech US VC Firms in 2025
Healthcare and biotech remain among the most capital-intensive and specialized corners of venture capital. Unlike generalist technology investing, backing a therapeutics or diagnostics company requires deep scientific diligence, patience through long development timelines, and fluency in regulatory and reimbursement pathways. The firms that have built […]
Read insight
Venture Capital · October 15, 2024
Top US Life Sciences VC Firms in 2025
Life sciences founders face a longer, more capital-intensive path to market than almost any other startup category, and the investors who back them need deep scientific fluency alongside patient capital. As 2025 approaches, a core group of US venture firms continues to anchor the therapeutics, […]
Read insightVenture Capital · February 9, 2024
Top US Life Sciences VC Firms in 2024
Venture capital firms are pivotal in propelling the life sciences sector forward, providing not just financial backing but also strategic support to startups aiming to innovate the space. In 2024, the landscape of venture capital in the life sciences sector in the United States is vibrant and diverse, with several firms standing out due to […]
Read insightVenture Capital · October 13, 2023
Top 10 Healthcare/Biotech US VC Firms in 2023
In the dynamic landscape of healthcare and biotechnology, venture capital firms play a crucial role in fueling innovations that have the potential to redefine the industry. The year 2023 has seen a myriad of venture capital firms making significant strides in investing in promising startups within the healthcare and biotech sectors. In this article, we […]
Read insightValuation · March 16, 2023
Valuation Models for Biotechnology Startups
Posted: Mar 16, 2023 4:19 PM ET Biotechnology startups are becoming increasingly important to us as the world rushes towards a more digitalized and globalized future. With technology advancing faster than ever before, it is essential for companies to understand the potential value of their biotechnological investments in order to maximize their return on investment. […]
Read insightVenture Capital · March 16, 2021
Biotech Venture Capital Firms
Posted: Mar 16, 2021 9:00 AM ET | Last Updated: Mar 16 Although venture capital deals were slightly down in 2020 as a result of the Covid-19 pandemic, the venture capital outlook for the biotech industry is expected to be strong in 2021. The pandemic has placed a greater importance on technological and medical innovation, […]
Read insightYou’ve reached the end — all 9 insights shown.
Make your next move
A new chapter.
A different kind of advisor.
Tell us where you want to go. We’ll help you build a strategy to get there.